Novartis Australia has partnered with MedAdvisor to deliver the Kisqali SPARK KONNECT Program available in Health Services Hub of your PlusOne console. The program has been developed for patients who have been prescribed Kisqali for the management of metastatic breast cancer and their treatment.

Pharmacists will be provided additional Kisqali support through resources that will help with administering the medication such as clinical updates, dosing and management information which will all be available through the Health Services Hub in the PlusOne console.

The SPARK KONNECT Program provides support to patients through resources which are all simple to use and can be easily accessed from a phone, tablet or computer.

A patient website Offering information, videos, tip sheets and patient testimonials that support patients in managing metastatic breast cancer and their treatment	SMS and email messages That provide reminders, motivational messages and links to more information	An app To help your patients keep track of their Kisqali treatment and medical appointments

For more information on the SPARK KONNECT Program and how it can support your patients, click the button below.

To access more information on Kisqali and the SPARK KONNECT program, you can download the resources below.

Please note the resources below are not for patient distribution.

For more information, please contact the MedAdvisor Customer Support Team on 1300 125 343.